Login to Your Account



Kalypsys Selected By NIH For Potential $30M Genomics Deal

By Kim Coghill


Thursday, June 10, 2004
The National Institutes of Health agreed to pay Kalypsys Inc. up to $30 million over four years for access to the firm's technology, which is expected to help scientists efficiently and simultaneously screen a broad portfolio of biological assays. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription